Christal Mickle
Founder bij ZEVRA THERAPEUTICS, INC.
Vermogen: 772 508 $ op 31-03-2024
Profiel
Christal M.
M.
Mickle is the founder and the Chief Development Officer at Zevra Therapeutics, Inc., a company founded in 2006.
Prior to her current position, she worked as a Research Associate at New River Pharmaceuticals, Inc. from 2002 to 2005.
Ms. Mickle holds a graduate degree from the University of Virginia, which was conferred in 2005, and an undergraduate degree from Virginia Polytechnic Institute & State University, which was conferred in 2001.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0.32% | 22-03-2024 | 133 191 ( 0.32% ) | 772 508 $ | 31-03-2024 |
Actieve functies van Christal Mickle
| Bedrijven | Functie | Begin |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Founder | 30-10-2006 |
Eerdere bekende functies van Christal Mickle
| Bedrijven | Functie | Einde |
|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
